Literature DB >> 17560118

TGF-beta(1) gene polymorphism in psoriasis vulgaris.

Wojciech Baran1, Jacek C Szepietowski, Grzegorz Mazur, Eugeniusz Baran.   

Abstract

Overexpression of TGF-beta(1) has been implicated in the pathology of many inflammatory diseases, including psoriasis. This study was performed to investigate the association between TGF-beta(1) single nucleotide polymorphism and susceptibility for psoriasis vulgaris. DNA from 78 patients with psoriasis vulgaris and 74 healthy volunteers was investigated. Polymorphism of TGF-beta(1) gene in codon 10 (T/C) and codon 25 (G/C) was evaluated by PCR-SSP and the results were compared between group of psoriatic patients, divided into early onset of psoriasis (type I) and late onset of psoriasis (type II) subgroups, and control healthy subjects. Frequencies in genotypes were similar between patients and control group (p >0.7), but between type I and type II psoriasis patients highly significant difference was found (p <0.0003). Higher frequency of CC/GG (intermediate producer) and TC/GG (high producer) was noted in the type I group, but the second high producer genotype (TT/GG) was more common in type II group. Also between type II psoriasis patients and healthy controls statistically significant difference was found (p <0.000001). In analyzing frequencies of carriage and alleles no significant differences were found. TGF-beta(1) gene polymorphism in codon 10 and 25 is not associated with susceptibility to psoriasis vulgaris, but may be important for the type of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560118     DOI: 10.1016/j.cyto.2007.04.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

Review 1.  Psoriasis: An Immunogenetic Perspective.

Authors:  Ayca Kocaaga; Mustafa Kocaaga
Journal:  Glob Med Genet       Date:  2022-06-13

2.  Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway.

Authors:  Erin L Fitch; Heather L Rizzo; Stephen E Kurtz; Keith W Wegmann; Wei Gao; Jacqueline M Benson; David J Hinrichs; Andrew Blauvelt
Journal:  J Invest Dermatol       Date:  2009-04-09       Impact factor: 8.551

3.  Transforming growth factor-β1 gene polymorphism in psoriasis vulgaris.

Authors:  Heba H El-Hadidi; Akmal S Hassan; Ghada El-Hanafy; Khalda S Amr; Sameh F Abdelmesih; Mahmoud F Abdelhamid
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-08-22

4.  TGF-β1 Gene Polymorphism and Its Correlation with Serum Level of TGF-β1 in Psoriasis Vulgaris Among Iraqi People.

Authors:  Bryar T Ahmed; Mohammad Y Saeed; Saman H Noori; Dashty M Amin
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-11-24

5.  EZH2 is involved in psoriasis progression by impairing miR-125a-5p inhibition of SFMBT1 and leading to inhibition of the TGFβ/SMAD pathway.

Authors:  Shengming Qu; Zhe Liu; Bing Wang
Journal:  Ther Adv Chronic Dis       Date:  2021-04-15       Impact factor: 5.091

6.  Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.

Authors:  Anna Michalak-Stoma; Joanna Bartosińska; Małgorzata Kowal; Maria Juszkiewicz-Borowiec; Agnieszka Gerkowicz; Grażyna Chodorowska
Journal:  Dis Markers       Date:  2013-10-31       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.